Literature DB >> 8518672

Sickle cell disease: the case for coordinated information.

A Streetly, M Dick, M Layton.   

Abstract

Mesh:

Year:  1993        PMID: 8518672      PMCID: PMC1677965          DOI: 10.1136/bmj.306.6891.1491

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Using a mock trial to make a difficult clinical decision.

Authors:  R Smith
Journal:  BMJ       Date:  1992-11-21

2.  Newborn screening for sickle cell disease: effect on mortality.

Authors:  E Vichinsky; D Hurst; A Earles; K Kleman; B Lubin
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

3.  Cost-effectiveness of neonatal screening for sickle cell disease.

Authors:  P A Lane; J R Eckman
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

4.  The vaso-occlusive crisis of sickle cell disease.

Authors:  S C Davies
Journal:  BMJ       Date:  1991-06-29

5.  Neonatal screening for sickle cell disease: a cost-effectiveness analysis.

Authors:  J Tsevat; J B Wong; S G Pauker; M H Steinberg
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

6.  Assessment of care of children with sickle cell disease: implications for neonatal screening programmes.

Authors:  R I Milne
Journal:  BMJ       Date:  1990-02-10

7.  Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.

Authors:  M E Horn; M C Dick; B Frost; L R Davis; A J Bellingham; C E Stroud; J W Studd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

8.  Patterns of mortality in sickle cell disease in the United Kingdom.

Authors:  A Gray; E N Anionwu; S C Davies; M Brozovic
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

9.  Review of neonatal screening programme for phenylketonuria.

Authors:  I Smith; B Cook; M Beasley
Journal:  BMJ       Date:  1991-08-10
  9 in total
  5 in total

1.  A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports.

Authors:  A Streetly
Journal:  BMJ       Date:  2000-05-20

2.  Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study.

Authors:  K Maxwell; A Streetly; D Bevan
Journal:  BMJ       Date:  1999-06-12

3.  Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London.

Authors:  A Streetly; C Grant; G Bickler; P Eldridge; S Bird; W Griffiths
Journal:  BMJ       Date:  1994-08-06

4.  Neurological 'soft' signs may identify children with sickle cell disease who are at risk for stroke.

Authors:  E Mercuri; J C Faundez; I Roberts; S Flora; H Bouza; F Cowan; J Pennock; G Bydder; L Dubowitz
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

5.  Experiences of hospital care and treatment-seeking behavior for pain from sickle cell disease: qualitative study.

Authors:  K Maxwell; A Streetly; D Bevan
Journal:  West J Med       Date:  1999-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.